<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>International Travel Medicine Center of Iran</PublisherName>
				<JournalTitle>International Journal of Travel Medicine and Global Health</JournalTitle>
				<Issn>2322-1100</Issn>
				<Volume>12</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>06</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Evaluation of apparent diffusion coefficient values in discriminating concurrent differential diagnosis of Glioblastoma, lymphoma, and metastatic tumors</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>90</FirstPage>
			<LastPage>109</LastPage>
			<ELocationID EIdType="pii">194220</ELocationID>
			
<ELocationID EIdType="doi">10.30491/ijtmgh.2023.431376.1395</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mersad</FirstName>
					<LastName>Mehrnahad</LastName>
<Affiliation>Qom University of Medical Sciences, Qom, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Morteza Sanei</FirstName>
					<LastName>Taheri</LastName>
<Affiliation>Department of Radiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Farnaz</FirstName>
					<LastName>Kimia</LastName>
<Affiliation>Department of Radiology, Qom University of Medical Sciences, Qom, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hamidreza</FirstName>
					<LastName>Saligheh Rad</LastName>
<Affiliation>Quantitative MR Imaging and Spectroscopy Group (QMISG), Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Robabeh Ghodssi</FirstName>
					<LastName>Ghassem Abadi</LastName>
<Affiliation>Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>12</Month>
					<Day>21</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Introduction: &lt;/strong&gt;Apparent diffusion coefficient (ADC) statistics can be valuable in distinguishing three types of brain tumors. The aim is to evaluate the capability of volume under the receiver operating characteristic (ROC) surface (VUS) for concurrent differential diagnosis of glioblastoma (GBM), lymphoma (LYM), and metastatic tumor(s) (MTTs) lesions of brain malignancies.&lt;br /&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Investigated Magnetic Resonance Imaging (MRI) included 57 GBM, 25 LYM, and 25 MTT that were pathological diagnoses, after MR imaging. Region of interest (ROI) was taken from tumor regions (TUMOR), enhancement area (ENHANCED), and peritumoral edema (EDEM) regions. ADC maps were obtained after selecting a region of interest, and First-Order Histogram Features (FOHs) were extracted. Statistical analysis was performed by MedCalc version 15.8 for comparison of continuous variables between three groups of lesions and plotting the ROC curves. For VUS and correct classification rates (CCR) calculations the R software v2.13.1 with the DiagTest3grp package was used. The confidence interval level was 95% for significant results. Diagnostic accuracy of ADC in the differentiation of mentioned three groups was performed using ROC surface.&lt;br /&gt;&lt;strong&gt;Results&lt;/strong&gt;: ADC&lt;sub&gt;Min&lt;/sub&gt;, ADC&lt;sub&gt;75 &lt;/sub&gt;and ADC&lt;sub&gt;95 Percentile&lt;/sub&gt; values in TUMOR groups of ROI, ADC&lt;sub&gt;Maximum&lt;/sub&gt;, ADC&lt;sub&gt;Min&lt;/sub&gt;,&lt;sub&gt; &lt;/sub&gt;ADC&lt;sub&gt;Mean,&lt;/sub&gt; ADC&lt;sub&gt;Median , &lt;/sub&gt;ADC&lt;sub&gt;Uniformity&lt;/sub&gt; and ADC&lt;sub&gt;Entropy  &lt;/sub&gt;in ENHANCED  and ADC&lt;sub&gt;25&lt;/sub&gt;, ADC&lt;sub&gt;75&lt;/sub&gt;,&lt;sub&gt; &lt;/sub&gt;ADC&lt;sub&gt;95 Percentiles&lt;/sub&gt;, ADC&lt;sub&gt;Mean &lt;/sub&gt;, ADC&lt;sub&gt;Normal Mean , &lt;/sub&gt;ADC&lt;sub&gt;Median&lt;/sub&gt;, ADC&lt;sub&gt;Entropy&lt;/sub&gt;, ADC&lt;sub&gt;Third Moment &lt;/sub&gt;and ADC&lt;sub&gt;StandardDeviation &lt;/sub&gt;in EDEM had significant VUS values results among GBM, LYM and MTTs .&lt;br /&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;VUS analysis is a helpful statistical method for categorizing types of brain tumors. Using the application of FOHs and proposed cut-off points for them by the VUS analysis, the differentiation of more than two types of brain tumors would be possible, concurrently. This will help neurologists and neurosurgeons to plan their treatment and surgery or monitor the status of patients’ therapeutic needs. </Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Apparent diffusion coefficient</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Glioblastoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Lymphoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Magnetic resonance imaging</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">ROC surface (VUS)</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijtmgh.com/article_194220_248b9c3fd67ecc9075a5e0410ece4995.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
